Cargando…

Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance

Detailing the connection between homeostatic functions of enzymatic families and eventual progression into tumorigenesis is crucial to our understanding of anti-cancer therapies. One key enzyme group involved in this process is the Poly (ADP-ribose) polymerase (PARP) family, responsible for an expan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lovsund, Taylor, Mashayekhi, Fatemeh, Fitieh, Amira, Stafford, James, Ismail, Ismail Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378431/ https://www.ncbi.nlm.nih.gov/pubmed/37508568 http://dx.doi.org/10.3390/cells12141904

Ejemplares similares

The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability
por: Fitieh, Amira, et al.
Publicado: (2021)

The Role of DNA Repair in Genomic Instability of Multiple Myeloma
por: Ali, Jana Yasser Hafez, et al.
Publicado: (2022)

SUMOylation mediates CtIP’s functions in DNA end resection and replication fork protection
por: Locke, Andrew J, et al.
Publicado: (2021)

Protocol to measure end resection intermediates at sequence-specific DNA double-strand breaks by quantitative polymerase chain reaction using ER-AsiSI U2OS cells
por: Sharma, Ajit K., et al.
Publicado: (2022)

Quantification of protein enrichment at site-specific DNA double-strand breaks by chromatin immunoprecipitation in cultured human cells
por: Sharma, Ajit K., et al.
Publicado: (2022)

Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
por: McMullen, Michelle, et al.
Publicado: (2020)

Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
por: Soung, Young-Hwa, et al.
Publicado: (2023)

Mechanism of PARP inhibitor resistance and potential overcoming strategies
por: Fu, Xiaoyu, et al.
Publicado: (2023)

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Kim, Hyoung, et al.
Publicado: (2020)

PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
por: Miller, Rowan E, et al.
Publicado: (2022)

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?
por: Ray-Coquard, Isabelle, et al.
Publicado: (2020)

Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical Landscape
por: Prados-Carvajal, Rosario, et al.
Publicado: (2021)

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
por: Murai, Junko, et al.
Publicado: (2016)

Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
por: Klotz, Daniel Martin, et al.
Publicado: (2020)

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
por: Yalon, Michal, et al.
Publicado: (2016)

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance
por: Kyo, Satoru, et al.
Publicado: (2022)

Biomarkers beyond BRCA: promising combinatorial treatment strategies in overcoming resistance to PARP inhibitors
por: Chu, Yu-Yi, et al.
Publicado: (2022)

The HSF1–PARP13–PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis
por: Fujimoto, Mitsuaki, et al.
Publicado: (2017)

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
por: Swindall, Amanda F., et al.
Publicado: (2013)

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
por: Yalon, Michal, et al.
Publicado: (2016)

Arsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cells
por: Liu, Hanyu, et al.
Publicado: (2016)

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
por: Yang, Xiao-Dong, et al.
Publicado: (2021)

PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them
por: Kim, Dongha, et al.
Publicado: (2022)

PARP inhibitor resistance: the underlying mechanisms and clinical implications
por: Li, He, et al.
Publicado: (2020)

Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
por: Moscvin, Maria, et al.
Publicado: (2021)

PARP10 promotes cellular proliferation and tumorigenesis by alleviating replication stress
por: Schleicher, Emily M, et al.
Publicado: (2018)

SPDR-01 INHIBITION OF HOMOLOGOUS RECOMBINATION, PARP INHIBITOR, OR DIANHYDROGALACTITOL OVERCOMES TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS
por: Ohba, Shigeo, et al.
Publicado: (2019)

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
por: Ding, Liya, et al.
Publicado: (2023)

Unraveling a New Role for Claudins in Gastric Tumorigenesis
por: Hagen, Susan J.
Publicado: (2019)

Mechanisms of PARP1 inhibitor resistance and their implications for cancer treatment
por: Jackson, Lindsey M, et al.
Publicado: (2022)

Unravelling and overcoming the challenges in the electrocatalytic reduction of fructose to sorbitol
por: Creus, Jordi, et al.
Publicado: (2023)

Intestinal Iron Homeostasis and Colon Tumorigenesis
por: Xue, Xiang, et al.
Publicado: (2013)

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance
por: Li, Yang, et al.
Publicado: (2023)

Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer
por: Brodie, Seth A., et al.
Publicado: (2015)

PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies
por: Lee, Elizabeth K., et al.
Publicado: (2020)

Editorial: The model of Ramadan diurnal intermittent fasting: unraveling the health implications, volume II
por: Faris, MoezAlIslam Ezzat, et al.
Publicado: (2023)

Occludin Is Involved in Adhesion, Apoptosis, Differentiation and Ca(2+)-Homeostasis of Human Keratinocytes: Implications for Tumorigenesis
por: Rachow, Susanne, et al.
Publicado: (2013)

New Insights into the Roles of lncRNAs as Modulators of Cytoskeleton Architecture and Their Implications in Cellular Homeostasis and in Tumorigenesis
por: García-Padilla, Carlos, et al.
Publicado: (2022)

Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
por: Zhang, Xudong, et al.
Publicado: (2023)

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis—an updated review
por: Dubois, Fatéméh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9a0vdmdpcibvtsmsiogppgtimj